HuaXi hospital
HuaXi hospital
Chengdu, Sichuan, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lenvatinib Combined With TACE and Camrelizumab in Conversion Resection for Advanced Hepatocellular Carcinoma (LEN-TAC Study) | Advanced Hepatocellular Carcinoma | Recruiting | Phase 3 | 2024-04-24 | NCT05738616 |